Venture Lender Runway Extends Life Science Push With New Loans

Venture debt provider Runway Growth Capital is extending its push into lending to the life sciences sector, where companies are taking advantage of technological inefficiencies exposed in the pandemic.

The Woodside, California-based firm has provided a $50 million senior secured term loan to Vero Biotech, which treats patients with a variety of pulmonary and cardiac diseases, according to a statement. Runway also recently closed a term loan of the same size to Gynesonics, a women’s health care company which develops minimally-invasive transcervical technologies, per a separate statement.

“It’s a good time to be investing in this space given ...